Bulletin

Investor Alert

Teva Pharmaceutical Industries Ltd. ADR

NYS: TEVA

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Teva Pharmaceutical Industries Ltd. ADR

After Hours

--Real time quotes

Jan 21, 2022, 6:38 p.m.

TEVA

/zigman2/quotes/205657894/composite

8.47

Change

-0.04 -0.47%

Volume

Volume 51,580

Real time quotes

/zigman2/quotes/205657894/composite

Today's close

$ 8.64

$ 8.51

Change

-0.13 -1.50%

Day low

Day high

$8.45

$8.72

52 week low

52 week high

$7.73

$13.30

Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Teva Pharmaceutical Industries Ltd. ADR

View Ratios

Fiscal year is January-December. All values ILS millions.	2016	2017	2018	2019	2020	5-year trend
Sales/Revenue	84.08B	80.52B	65.69B	60.12B	57.29B
Sales Growth	-	-4.24%	-18.42%	-8.48%	-4.70%
Cost of Goods Sold (COGS) incl. D&A	38.56B	42.34B	35.86B	33.32B	30.72B
COGS excluding D&A	32.82B	34.87B	29.24B	27.18B	25.37B
Depreciation & Amortization Expense	5.74B	7.47B	6.62B	6.14B	5.35B
Depreciation	1.92B	2.27B	2.43B	2.17B	1.85B
Amortization of Intangibles	3.81B	5.19B	4.19B	3.97B	3.51B
COGS Growth	-	9.80%	-15.29%	-7.10%	-7.79%
Gross Income	45.52B	38.18B	29.83B	26.8B	26.57B
Gross Income Growth	-	-16.13%	-21.88%	-10.14%	-0.86%
Gross Profit Margin	-	-	-	-	46.38%	NA

	2016	2017	2018	2019	2020	5-year trend
SG&A Expense	27.85B	23.83B	19.51B	17.16B	16.05B
Research & Development	8.1B	6.4B	4.36B	3.6B	3.43B
Other SG&A	19.75B	17.43B	15.15B	13.56B	12.62B
SGA Growth	-	-14.46%	-18.11%	-12.05%	-6.45%
Other Operating Expense	-	-	-	-	-
Unusual Expense	11.95B	81.2B	16.96B	11.1B	23.29B
EBIT after Unusual Expense	(11.95B)	(81.2B)	(16.96B)	(1.46B)	(12.78B)
Non Operating Income/Expense	(644.91M)	3.26B	553.67M	213.78M	137.56M
Non-Operating Interest Income	195.78M	302.15M	140.22M	146.08M	82.54M
Equity in Affiliates (Pretax)	-	-	-	-	-
Interest Expense	2.1B	2.83B	3.38B	3.41B	2.6B
Interest Expense Growth	-	34.57%	19.38%	0.90%	-23.85%
Gross Interest Expense	2.1B	2.83B	3.38B	3.41B	2.6B
Interest Capitalized	-	-	-	-	-
Pretax Income	3.16B	(66.11B)	(9.33B)	(4.51B)	(15.15B)
Pretax Income Growth	-	-2,189.97%	85.88%	51.71%	-236.18%
Pretax Margin	-	-	-	-	-26.45%	NA
Income Tax	2B	(6.95B)	(701.08M)	(990.52M)	(577.76M)
Income Tax - Current Domestic	1.85B	1.34B	2.52B	3.15B	625.9M
Income Tax - Current Foreign	-	-	-	-	-
Income Tax - Deferred Domestic	153.55M	(8.29B)	(3.22B)	(4.14B)	(1.2B)
Income Tax - Deferred Foreign	-	-	-	-	-
Income Tax Credits	-	-	-	-	-
Equity in Affiliates	30.71M	(10.79M)	(255.26M)	(46.32M)	474.59M
Other After Tax Income (Expense)	-	-	-	-	-
Consolidated Net Income	1.19B	(59.17B)	(8.89B)	(3.56B)	(14.1B)
Minority Interest Expense	(69.1M)	(661.84M)	(1.16B)	(3.56M)	(378.29M)
Net Income	1.26B	(58.5B)	(7.73B)	(3.56B)	(13.72B)
Net Income Growth	-	-4,732.38%	86.79%	53.95%	-285.50%
Net Margin Growth	-	-	-	-	-23.95%	NA
Extraordinaries & Discontinued Operations	-	-	-	-	-
Extra Items & Gain/Loss Sale Of Assets	-	-	-	-	-
Cumulative Effect - Accounting Chg	-	-	-	-	-
Discontinued Operations	-	-	-	-	-
Net Income After Extraordinaries	1.26B	(58.5B)	(7.73B)	(3.56B)	(13.72B)
Preferred Dividends	1B	935.21M	895.22M	-	-
Net Income Available to Common	261.04M	(59.44B)	(8.63B)	(3.56B)	(13.72B)
EPS (Basic)	0.27	(58.50)	(8.45)	(3.26)	(12.53)
EPS (Basic) Growth	-	-21,506.48%	85.56%	61.38%	-284.10%
Basic Shares Outstanding	955M	1.02B	1.02B	1.09B	1.1B
EPS (Diluted)	0.27	(58.50)	(8.45)	(3.26)	(12.53)
EPS (Diluted) Growth	-	-21,640.46%	85.56%	61.38%	-284.10%
Diluted Shares Outstanding	961M	1.02B	1.02B	1.09B	1.1B
EBITDA	23.4B	21.82B	16.94B	15.78B	15.87B
EBITDA Growth	-	-6.76%	-22.39%	-6.85%	0.60%
EBITDA Margin	-	-	-	-	27.70%	NA

Trending Tickers

/zigman2/quotes/207505872/composite DISH+1.05%
/zigman2/quotes/204151124/composite CURE-1.23%
/zigman2/quotes/214908404/composite GFL+1.15%
/zigman2/quotes/204236046/composite DUST+1.32%
/zigman2/quotes/200683073/composite FRC+0.90%

MarketWatch.com

Follow MarketWatch
RSS
Podcasts

Copyright © 2022 MarketWatch, Inc. All rights reserved.
By using this site, you agree to the Subscriber Agreement & Terms of Use
Privacy Notice and Cookie Notice ().
Do Not Sell My Personal Information

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Teva Pharmaceutical Industries Ltd. ADR

Annual Financials for Teva Pharmaceutical Industries Ltd. ADR

Latest News

dow

nasdaq

s&p 500

Kiosk